Samantha Semenkow
Stock Analyst at Citigroup
(0)
# 4892
Out of 5,358 analysts
52
Total ratings
22.73%
Success rate
-23.91%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PRME Prime Medicine | Downgrades: Neutral | 10 2 | 1.69 | -11.24% | 3 | May 27, 2025 | |
CABA Cabaletta Bio | Maintains: Buy | 17 13 | 2.48 | 424.19% | 3 | May 16, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Buy | 8 4 | 1.43 | 179.72% | 3 | May 15, 2025 | |
ARGX argenx | Maintains: Strong Buy | 796 803 | 585.97 | 37.04% | 6 | May 9, 2025 | |
GPCR Structure Therapeuti... | Initiates Coverage On: Buy | 60 | 21.12 | 184.09% | 1 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 5 | 4.47 | 11.86% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 3 | n/a | n/a | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 3.53 | 239.94% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 27 31 | 25.86 | 19.88% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 15 | 2.84 | 428.17% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 4 | 0.35 | 1042.86% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 10 14 | 2.69 | 420.45% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 15 | 1.92 | 681.25% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 9 12 | n/a | n/a | 2 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 72 | 46.78 | 53.91% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 46 | n/a | n/a | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 33 50 | 16.77 | 198.15% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 56 | 18.55 | 201.89% | 3 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 1 | n/a | n/a | 3 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 6 | n/a | n/a | 1 | May 3, 2023 |